L. A. Santos

Diethylcarbamazine attenuates the expression of pro-fibrogenic markers and hepatic stellate cells activation in carbon tetrachloride-induced liver fibrosis

M. R. França, S. W. Rocha, W. Oliveira, 2018, Inflammopharmacology.

Diethylcarbamazine: Possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice

M. R. França, S. W. Rocha, W. Oliveira, 2015, Clinical and experimental pharmacology & physiology.

Diethylcarbamazine inhibits NF-κB activation in acute lung injury induced by carrageenan in mice.

M. R. França, S. W. Rocha, L. A. Santos, 2014, International immunopharmacology.

Diethylcarbamazine attenuates LPS-induced acute lung injury in mice by apoptosis of inflammatory cells

L. A. Santos, K. Barbosa, C. Peixoto, 2017, Pharmacological reports : PR.

A new diethylcarbamazine formulation (NANO‐DEC) as a therapeutic tool for hepatic fibrosis

M. R. França, W. Oliveira, L. A. Santos, 2018, International immunopharmacology.

Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice

M. R. França, S. W. Rocha, W. Oliveira, 2016, Brain Research.

Reduction of carrageenan-induced acute pulmonary inflammation in mice by novel thiazolidinedione derivative LPSF/RA-4.

M. R. França, S. W. Rocha, L. A. Santos, 2013, European journal of pharmacology.